Eisai
4523.T
#2125
Rank
A$13.65 B
Marketcap
A$48.43
Share price
0.31%
Change (1 day)
8.62%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2025 (TTM): A$1.31

According to Eisai's latest financial reports the company's current EPS (TTM) is A$1.28. In 2026 the company made an earnings per share (EPS) of A$1.27 a decrease over its 2025 EPS that were of A$1.61.

EPS history for Eisai from 2000 to 2025

Annual EPS

Year EPS Change
2026A$1.27-21.04%
2025A$1.6111.85%
2024A$1.44-32.63%
2023A$2.145.52%
2022A$2.03-74.01%
2021A$7.80-66.58%
2020A$23.3498.24%
2019A$11.7817.01%
2018A$10.0637.78%
2017A$7.30-27.62%
2016A$10.0935.33%
2015A$7.46-2.82%
2014A$7.67-27.66%
2013A$10.61-27.49%
2012A$14.63-12.67%
2011A$16.7588.08%
2010A$8.91-11.06%
2009A$10.02-390.15%
2008A-$3.45-127.78%
2007A$12.43347.11%
2006A$2.784.38%
2005A$2.667.4%
2004A$2.4843.03%
2003A$1.7325.09%
2002A$1.3952.67%
2001A$0.9169.76%
2000A$0.53